Human papillomaviruses (HPVs) are etiological agents for many human diseases, including genital warts, skin warts, cervical cancer, and certain types of head-and-neck and skin cancers. Although two prophylactic vaccines against HPV infection are presently available and recommended for immunization of young girls/boys, therapeutic vaccines that are most needed for the majority of HPV-infected populations are still lacking. Since early protein 2 (E2) encoded by HPVs is crucial for viral DNA replication, HPV genome segregation, control of viral gene expression, and induction of cellular apoptosis and senescence, it has become a promising target for the development of anti-viral therapeutics. In the last funding period, we have identified bromodomain- containing protein 4 (Brd4) as a central cellular factor mediating diverse functions of HPV-encoded E2 protein, particularly via formation of an E2-Brd4 silencing complex able to block activator protein-1 (AP-1)-triggered gene activation from latent HPV chromatin that exhibits no transcriptional activity. In this renewal application, we propose three aims to dissect the mechanisms of HPV chromatin-dependent transcriptional regulation: 1. To define the mechanism of AP-1-dependent HPV chromatin transcription 2. To define the repression mechanism of E2-Brd4 in HPV chromatin transcription 3. To define HPV-specific versus global cellular gene transcription regulated by AP-1, Brd4, and E2 We will first apply an innovative HPV chromatin transcription system that we have developed to define the role of cellular chromatin-modifying enzymes, including p300 and CBP histone acetyltransferases (HATs), in AP-1-dependent activation of HPV chromatin transcription. We will then dissect the steps of E2-Brd4 silencing complex in suppressing HPV chromatin transcription and further elucidate the functional role of two newly identified Brd4-interacting proteins, i.e., G9a histone methyltransferase (HMT) and topoisomerase II?-binding protein 1 (TopBP1), in E2-regulated HPV transcription. To distinguish HPV-specific and global host cell gene transcription, we will also apply genome-wide approaches, in collaboration with Dr. Bing Ren at UC-San Diego, to analyze the transcriptional profiles and binding patterns of these HPV transcriptional regulators and chromatin modifiers, and with the help from Dr. Thomas Kodadek at Florida Scripps, we will utilize synthetic chemistry to develop small compounds blocking Brd4 action in HPV transcription. Our central hypothesis here is that conformational changes in Brd4 provide a molecular switch for Brd4 recruitment of distinct cellular factors to regulate HPV-specific and cellular gene transcription. The combination of mechanistic studies and genome-wide analyses will significantly advance our understanding of viral and cellular factors modulating HPV transcription and facilitate the development of therapeutic agents blocking HPV-induced human diseases.
Human papillomaviruses (HPVs) induces cervical cancer, penile cancer, oral cancer, genital warts, skin warts, and many other human diseases. Although prophylactic HPV vaccines developed by different investigators have recently become available, therapeutic vaccines that are most needed for HPV-infected individuals are still lacking. The research described in this application will unravel the role of viral and cellular proteins involve in HPV transcriptional regulation and gene expression, and further facilitate the development of drug inhibitors able to block HPV propagation.
|Fowler, Trent; Ghatak, Payel; Price, David H et al. (2014) Regulation of MYC expression and differential JQ1 sensitivity in cancer cells. PLoS One 9:e87003|
|Morales, Julio C; Richard, Patricia; Rommel, Amy et al. (2014) Kub5-Hera, the human Rtt103 homolog, plays dual functional roles in transcription termination and DNA repair. Nucleic Acids Res 42:4996-5006|
|Nagarajan, Sankari; Hossan, Tareq; Alawi, Malik et al. (2014) Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription. Cell Rep 8:460-9|
|Chiang, Cheng-Ming (2014) Nonequivalent response to bromodomain-targeting BET inhibitors in oligodendrocyte cell fate decision. Chem Biol 21:804-6|
|Wu, Shwu-Yuan; Lee, A-Young; Lai, Hsien-Tsung et al. (2013) Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol Cell 49:843-57|
|Quinlan, Edward J; Culleton, Sara P; Wu, Shwu-Yuan et al. (2013) Acetylation of conserved lysines in bovine papillomavirus E2 by p300. J Virol 87:1497-507|
|Rabellino, Andrea; Carter, Brandon; Konstantinidou, Georgia et al. (2012) The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA. Cancer Res 72:2275-84|
|Loewenstein, Paul M; Wu, Shwu-Yuan; Chiang, Cheng-Ming et al. (2012) The adenovirus E1A N-terminal repression domain represses transcription from a chromatin template in vitro. Virology 428:70-5|
|Cai, Di; Lee, A-Young; Chiang, Cheng-Ming et al. (2011) Peptoid ligands that bind selectively to phosphoproteins. Bioorg Med Chem Lett 21:4960-4|
|Wang, Wei-Ming; Wu, Shwu-Yuan; Lee, A-Young et al. (2011) Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription. J Biol Chem 286:40974-86|
Showing the most recent 10 out of 30 publications